Background
Insomnia is a prevalent sleep disorder and it has been increasingly associated with cardiovascular morbidity and mortality. The reasons for this relationship are not completely understood but may involve endothelial dysfunction. In this study, we hypothesized that insomnia symptoms would be associated with reduced endothelial function.
Methods
Working adults [n=496, 67.5% female, 78.6% white, mean age: 48.7±10.8 years, body mass index (BMI): 28.2±6.7 kg/m2, diabetes: 5.8%, hypertension: 20.0%, hyperlipidemia: 17.9%, heart disease: 2.6%] enrolled in the Emory-Georgia Tech Predictive Health Institute study completed baseline demographic, clinical, depression (Beck Depression Inventory II; BDI-II), anxiety (General Anxiety Disorder-7; GAD-7) sleep (Pittsburg Sleep Quality Index , PSQI) and non-invasive endothelial function (brachial artery flow-mediated dilation; FMD) measures. Insomnia symptoms were defined as subjective sleep latency of ≥ 30 minutes, nighttime or early morning awakenings and/or sleep medication use occurring ≥ 3 times per week in the past month.
Results
Insomnia symptoms were reported by 39.5% of participants. Multivariable regression models showed that insomnia symptoms, age, baseline artery diameter and dyslipidemia were inversely related to FMD. After adjusting for age, baseline artery diameter, and dyslipidemia participants reporting insomnia symptoms had lower FMD than participants reporting better sleep (adjusted FMD means= 6.13%±0.28 vs 6.83%±0.26, p=.035).
Conclusion
In this study insomnia symptoms were associated with reduced FMD. Research examining the therapeutic benefits of treating insomnia on endothelial function and future cardiovascular risk is warranted.